FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169295603> ?p ?o ?g. }

• W2169295603 endingPage "57" @default.
• W2169295603 startingPage "51" @default.
• W2169295603 abstract "Background/Objective: Although evidence of scorpion antivenin effectiveness in the clinical setting is lacking, scorpion antivenin is generally considered the only specific treatment for scorpion sting irrespective of its clinical severity. We conducted a matched-pair study to assess the efficacy of systematic administration of scorpion antivenin. Methods: Among 600 stung patients who participated in a study on the efficacy of high-dose hydrocortisone after scorpion sting, 135 (cases) had been treated with 10 to 20 mL intravenous scorpion antivenin (neutralizing 10 LD50 venom/mL). Controls were matched on disease severity on arrival to the emergency department. The severity of envenomation was graded I or II according to the absence (grade 1) or the presence (grade II) of systemic manifestations of scorpion envenomation. Assessment of scorpion antivenin efficacy was based on the rate of changing severity grade in both groups (clinical improvement or worsening during an observation period of at least 4 hours). Results: Both groups were similar with respect to clinical severity (36 patients were graded II in each group), age, sex, time-lapse between scorpion sting and ED arrival, and the administration of adjunctive therapy such as hydrocortisone. By the 4-hour evaluation, 50% and 64% of patients initially graded II exhibited a substantial clinical improvement in cases and controls, respectively, suggesting similar effects in cases and controls. There was no difference in preventive effect,: 13% and 10% of cases and controls developed systemic manifestations of scorpion envenomation during the 4-hour observation period; 23% of cases and 17% controls were hospitalized by this time. There was no difference in the duration of hospitalization. Three cases developed anaphylactic shock as a consequence of scorpion antivenin administration, while 1 scorpion antivenin-untreated patient died from refractory shock. Conclusion: Systematic administration of scorpion antivenin irrespective of clinical severity did not alter the clinical course of scorpion sting. A prospective study is needed concerning the response of the more severe scorpion envenomations." @default.
• W2169295603 created "2016-06-24" @default.
• W2169295603 creator A5000446603 @default.
• W2169295603 creator A5006853813 @default.
• W2169295603 creator A5013640509 @default.
• W2169295603 creator A5014545520 @default.
• W2169295603 creator A5015484573 @default.
• W2169295603 creator A5030688262 @default.
• W2169295603 creator A5039463442 @default.
• W2169295603 creator A5058189844 @default.
• W2169295603 creator A5070250927 @default.
• W2169295603 creator A5073959672 @default.
• W2169295603 creator A5086254432 @default.
• W2169295603 date "1999-01-01" @default.
• W2169295603 modified "2023-09-27" @default.
• W2169295603 title "Efficacy of Serotherapy in Scorpion Sting: A Matched-Pair Study" @default.
• W2169295603 cites W1971468537 @default.
• W2169295603 cites W1973620913 @default.
• W2169295603 cites W1977614522 @default.
• W2169295603 cites W1981915863 @default.
• W2169295603 cites W1985938599 @default.
• W2169295603 cites W1988763161 @default.
• W2169295603 cites W1993575080 @default.
• W2169295603 cites W2017508106 @default.
• W2169295603 cites W2029316597 @default.
• W2169295603 cites W2032002893 @default.
• W2169295603 cites W2051960477 @default.
• W2169295603 cites W2059441193 @default.
• W2169295603 cites W2063582418 @default.
• W2169295603 cites W2088033672 @default.
• W2169295603 cites W2092307414 @default.
• W2169295603 cites W2095470565 @default.
• W2169295603 cites W2095537936 @default.
• W2169295603 cites W2104811528 @default.
• W2169295603 cites W2152947312 @default.
• W2169295603 cites W2165068397 @default.
• W2169295603 cites W2265517402 @default.
• W2169295603 cites W2396485907 @default.
• W2169295603 doi "https://doi.org/10.1081/clt-100102408" @default.
• W2169295603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10078160" @default.
• W2169295603 hasPublicationYear "1999" @default.
• W2169295603 type Work @default.
• W2169295603 sameAs 2169295603 @default.
• W2169295603 citedByCount "38" @default.
• W2169295603 countsByYear W21692956032013 @default.
• W2169295603 countsByYear W21692956032014 @default.
• W2169295603 countsByYear W21692956032016 @default.
• W2169295603 countsByYear W21692956032017 @default.
• W2169295603 countsByYear W21692956032018 @default.
• W2169295603 countsByYear W21692956032019 @default.
• W2169295603 crossrefType "journal-article" @default.
• W2169295603 hasAuthorship W2169295603A5000446603 @default.
• W2169295603 hasAuthorship W2169295603A5006853813 @default.
• W2169295603 hasAuthorship W2169295603A5013640509 @default.
• W2169295603 hasAuthorship W2169295603A5014545520 @default.
• W2169295603 hasAuthorship W2169295603A5015484573 @default.
• W2169295603 hasAuthorship W2169295603A5030688262 @default.
• W2169295603 hasAuthorship W2169295603A5039463442 @default.
• W2169295603 hasAuthorship W2169295603A5058189844 @default.
• W2169295603 hasAuthorship W2169295603A5070250927 @default.
• W2169295603 hasAuthorship W2169295603A5073959672 @default.
• W2169295603 hasAuthorship W2169295603A5086254432 @default.
• W2169295603 hasConcept C117287731 @default.
• W2169295603 hasConcept C126322002 @default.
• W2169295603 hasConcept C127413603 @default.
• W2169295603 hasConcept C145600735 @default.
• W2169295603 hasConcept C146978453 @default.
• W2169295603 hasConcept C18903297 @default.
• W2169295603 hasConcept C2777884321 @default.
• W2169295603 hasConcept C2779300339 @default.
• W2169295603 hasConcept C2779448229 @default.
• W2169295603 hasConcept C42219234 @default.
• W2169295603 hasConcept C71924100 @default.
• W2169295603 hasConcept C86803240 @default.
• W2169295603 hasConceptScore W2169295603C117287731 @default.
• W2169295603 hasConceptScore W2169295603C126322002 @default.
• W2169295603 hasConceptScore W2169295603C127413603 @default.
• W2169295603 hasConceptScore W2169295603C145600735 @default.
• W2169295603 hasConceptScore W2169295603C146978453 @default.
• W2169295603 hasConceptScore W2169295603C18903297 @default.
• W2169295603 hasConceptScore W2169295603C2777884321 @default.
• W2169295603 hasConceptScore W2169295603C2779300339 @default.
• W2169295603 hasConceptScore W2169295603C2779448229 @default.
• W2169295603 hasConceptScore W2169295603C42219234 @default.
• W2169295603 hasConceptScore W2169295603C71924100 @default.
• W2169295603 hasConceptScore W2169295603C86803240 @default.
• W2169295603 hasIssue "1" @default.
• W2169295603 hasLocation W21692956031 @default.
• W2169295603 hasLocation W21692956032 @default.
• W2169295603 hasOpenAccess W2169295603 @default.
• W2169295603 hasPrimaryLocation W21692956031 @default.
• W2169295603 hasRelatedWork W2005200083 @default.
• W2169295603 hasRelatedWork W2030070227 @default.
• W2169295603 hasRelatedWork W2125629882 @default.
• W2169295603 hasRelatedWork W2167760828 @default.
• W2169295603 hasRelatedWork W2465492141 @default.
• W2169295603 hasRelatedWork W2519576479 @default.
• W2169295603 hasRelatedWork W2908500081 @default.

• next